SMILES,Name,Conditions,NCT_Number,Phases,Unapproval Probability,Approval Probability
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,_PROGESTERONE,TRAUMATIC BRAIN INJURY,NCT04426487,Early Phase 1,0.15139005617883886,0.8486099438211611
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,_ESTRADIOL,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.05626452908224711,0.9437354709177532
CC(=O)[O-],_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.0726861190112207,0.9273138809887792
CC(=O)[O-],_ACETATE,BURN,NCT01413620,Phase 1,0.014813266939616144,0.9851867330603838
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,OVARIAN CANCER,NCT04460807,Phase 3,0.02424349651615234,0.9757565034838476
CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,_GOSERELIN,BREAST NEOPLASM,NCT01723774,Phase 2,0.2367154783051228,0.7632845216948767
C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,_FULVESTRANT,NEOPLASMS,NCT02530411,Phase 2,0.1118453518663695,0.8881546481336307
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,_LETROZOLE,OVARIAN CANCER,NCT03378297,Early Phase 1,0.04112072958611645,0.9588792704138832
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.009752642982408823,0.9902473570175911
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,PARKINSON'S DISEASE,NCT04127578,Phase 1|Phase 2,0.051542410763939096,0.9484575892360608
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASMS,NCT03693612,Phase 2,0.145953394440728,0.8540466055592723
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.2299670548459344,0.7700329451540656
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASM METASTASIS,NCT00781612,Phase 2,0.0782393394801775,0.9217606605198224
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PROSTATE CANCER,NCT04194554,Phase 1|Phase 2,0.3925296633516663,0.6074703366483335
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,BREAST CANCER,NCT02826512,Phase 2,0.3488100758199375,0.6511899241800622
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,METASTATIC MELANOMA,NCT03925350,Phase 2,0.4004352093877469,0.5995647906122528
CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21,_VALACYCLOVIR,PROSTATE CANCER,NCT01436968,Phase 3,0.030122030957779093,0.9698779690422212
CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21,_VALACICLOVIR,PROSTATE CANCER,NCT01436968,Phase 3,0.030122030957779093,0.9698779690422212
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,OVARIAN CANCER,NCT03464201,Phase 2,0.3445386515200887,0.6554613484799111
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,BREAST CANCER,NCT02955394,Phase 2,0.3606222087276321,0.6393777912723676
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.09145447700195243,0.9085455229980476
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,NEOPLASMS,NCT03967223,Phase 2,0.11304089574639352,0.8869591042536064
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PROSTATE CANCER,NCT03089203,Phase 1,0.08169323068875999,0.91830676931124
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,METASTATIC MELANOMA,NCT03475134,Phase 1,0.05334599559317312,0.9466540044068268
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,EPIDERMOLYSIS BULLOSA,NCT01033552,Phase 2,0.09111978403575148,0.9088802159642484
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS,NCT02953184,Phase 2,0.0590950865128629,0.9409049134871372
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OSTEOSARCOMA,NCT03063983,Phase 2,0.015526125774568309,0.9844738742254316
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,BREAST CANCER,NCT02897700,Phase 1,0.030968194579589457,0.9690318054204105
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,OSTEOSARCOMA,NCT03063983,Phase 2,0.015830446188837964,0.984169553811162
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,JUVENILE IDIOPATHIC ARTHRITIS,NCT04169828,Not Applicable,0.010130708341138887,0.9898692916588608
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,EPIDERMOLYSIS BULLOSA,NCT02582775,Phase 2,0.06291776405749305,0.9370822359425072
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,LYMPHEDEMA,NCT04390685,Phase 1|Phase 2,0.0810751305170388,0.9189248694829611
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,EPIDERMOLYSIS BULLOSA,NCT02582775,Phase 2,0.8493340378391916,0.15066596216080833
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.9470895184903994,0.052910481509600565
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,NEOPLASMS,NCT03967223,Phase 2,0.9660315000998054,0.03396849990019462
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,METASTATIC MELANOMA,NCT03475134,Phase 1,0.9623679408123974,0.03763205918760252
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,EPIDERMOLYSIS BULLOSA,NCT01033552,Phase 2,0.9977036688237032,0.0022963311762967823
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEPATOCELLULAR CARCINOMA,NCT02905188,Phase 1,0.999684894120146,0.0003151058798540942
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.22133319570381704,0.778666804296183
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,BREAST NEOPLASM MALIGNANT FEMALE,NCT04198727,Not Applicable,0.22514145478959766,0.7748585452104022
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,OVARIAN CANCER,NCT03936270,Phase 2,0.4126398902083907,0.587360109791609
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.13005710537436468,0.8699428946256353
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,PROSTATE CANCER,NCT02905318,Phase 2,0.4376542127767527,0.562345787223247
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,FEMALE BREAST CARCINOMA,NCT02942355,Phase 2,0.3921080564740075,0.6078919435259924
CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,_ANASTROZOLE,FEMALE BREAST CARCINOMA,NCT02942355,Phase 2,0.12276622083767155,0.8772337791623283
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,SOFT TISSUE SARCOMA,NCT03114527,Phase 2,0.18687860372613527,0.8131213962738646
CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,_RIBOCICLIB,BREAST NEOPLASM,NCT03283384,Phase 2,0.4688255727305533,0.5311744272694466
CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,_RIBOCICLIB,SOFT TISSUE SARCOMA,NCT03114527,Phase 2,0.49588370218138106,0.5041162978186189
CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,_RIBOCICLIB,EARLY BREAST CANCER,NCT03701334,Phase 3,0.4889434480003661,0.511056551999634
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.9577859658265684,0.04221403417343137
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,METASTATIC BREAST CANCER,NCT03901339,Phase 3,0.9179946168010464,0.08200538319895344
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASMS,NCT03693612,Phase 2,0.17599532692059294,0.8240046730794071
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASM METASTASIS,NCT00781612,Phase 2,0.15417234708494512,0.8458276529150548
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,GASTROINTESTINAL STROMAL TUMORS,NCT03944304,Phase 2,0.10336658313865436,0.8966334168613457
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,OVARIAN CANCER,NCT03378297,Early Phase 1,0.3401125709478486,0.6598874290521514
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,BREAST NEOPLASM,NCT03740893,Phase 2,0.35510220176265506,0.6448977982373446
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.2666658903027661,0.7333341096972336
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATE CANCER,NCT03810105,Phase 2,0.4297625462348878,0.5702374537651121
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,_ENTINOSTAT,BREAST NEOPLASM,NCT03280563,Phase 1|Phase 2,0.7225264450497522,0.27747355495024784
NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,_VASOPRESSIN,HYPERTENSION,NCT04170751,Not Applicable,0.177130752641262,0.8228692473587379
N=C(N)NCCC[C@H](N)C(=O)O,_ARGININE,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.26577873375867395,0.7342212662413259
N=C(N)NCCC[C@H](N)C(=O)O,_ARGININE,DENTAL CARIES,NCT03928587,Not Applicable,0.13420582908820436,0.8657941709117957
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,PARKINSON'S DISEASE,NCT04127578,Phase 1|Phase 2,0.09057820194426372,0.9094217980557364
NC[C@H](O)c1ccc(O)c(O)c1,_NOREPINEPHRINE,HYPERTENSION,NCT04170751,Not Applicable,0.514769737835491,0.485230262164509
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,LATERAL EPICONDYLITIS,NCT04201249,Phase 2|Phase 3,0.004325355112554266,0.9956746448874456
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,"PAIN, CHRONIC",NCT02983682,Phase 3,0.07331345448141184,0.926686545518588
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,CONTRACEPTION,NCT02799641,Not Applicable,0.004325355112554266,0.9956746448874456
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,SCAR,NCT02234193,Early Phase 1,0.0003159677607756102,0.9996840322392244
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,POST-DURAL PUNCTURE HEADACHE,NCT03560349,Phase 2,0.004325355112554266,0.9956746448874456
CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,_DAPTOMYCIN,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION,NCT04298463,,0.07853690357072089,0.921463096429279
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,METASTATIC MELANOMA,NCT03817125,Phase 1,0.011943949539229731,0.9880560504607704
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,ULCERATIVE COLITIS,NCT03759041,Phase 2,0.03316073850263745,0.9668392614973624
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION,NCT04298463,,0.0928750556570506,0.9071249443429494
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,OSTEOARTHRITIS,NCT04075526,Not Applicable,0.0035771704571429547,0.9964228295428571
CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,_TEICOPLANIN,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION,NCT04298463,,0.29715210316536234,0.7028478968346376
CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,_TEICOPLANIN,BACTERIAL INFECTIONS,NCT03933748,,0.2326406394740672,0.7673593605259328
CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O,_PIPERACILLIN,APPENDICITIS,NCT02991937,Not Applicable,0.06840945997034874,0.9315905400296512
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,_CYCLOSPORINE,EPIDERMOLYSIS BULLOSA,NCT01033552,Phase 2,0.1566946606473334,0.8433053393526664
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.0410314008198595,0.9589685991801404
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,EPIDERMOLYSIS BULLOSA,NCT01033552,Phase 2,0.2923627804870192,0.7076372195129808
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,BREAST CANCER,NCT01646034,Phase 3,0.2769245796025061,0.723075420397494
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,PARKINSON'S DISEASE,NCT04127578,Phase 1|Phase 2,0.1410316702824025,0.8589683297175976
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,DRY EYE,NCT04115800,Early Phase 1,0.05478967342114069,0.9452103265788594
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,ISCHEMIC HEART DISEASE,NCT03600961,,0.1488618865333341,0.8511381134666659
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,METASTATIC MELANOMA,NCT01920516,,0.7019252584226046,0.2980747415773957
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,DEPRESSION,NCT02837432,Early Phase 1,0.018601936026145658,0.9813980639738544
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,PROSTATE CANCER,NCT00859781,Phase 2,0.03956388903826909,0.9604361109617308
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,SEPSIS,NCT04160676,Not Applicable,0.004250917001135374,0.9957490829988646
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,HIV INFECTION,NCT03237689,Early Phase 1,0.10195884340035699,0.8980411565996428
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,OSTEOSARCOMA,NCT04154189,Phase 2,0.2969490863333532,0.7030509136666467
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISOLONE,POLYMYALGIA RHEUMATICA,NCT03576794,Phase 3,0.009335930393242532,0.9906640696067576
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,PROSTATE CANCER,NCT03513211,Phase 1|Phase 2,0.08386305676624035,0.9161369432337596
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,TYPE 1 DIABETES,NCT03428945,Phase 2,0.04319961599360704,0.9568003840063928
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,ANTERIOR CRUCIATE LIGAMENT INJURY,NCT03818932,Phase 2|Phase 3,0.002209358007737872,0.997790641992262
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,ANALGESIA,NCT03955211,Phase 2,0.14374563160646314,0.8562543683935369
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,MUSCULOSKELETAL INJURY,NCT03767933,Phase 2,0.002209358007737872,0.997790641992262
O=P1(NCCCl)OCCCN1CCCl,_IFOSFAMIDE,OSTEOSARCOMA,NCT04154189,Phase 2,0.14373683611000732,0.8562631638899926
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,VITILIGO,NCT04030988,Phase 1,0.0028715498938428874,0.9971284501061572
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,_DEXTROSE,HYSTERECTOMY,NCT03719755,Not Applicable,0.14439621344418987,0.8556037865558102
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,_DEXTROSE,OSTEO ARTHRITIS OF THE KNEES,NCT03400631,Not Applicable,0.08796014006705652,0.9120398599329436
C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,_SOMATOSTATIN,HEPATOCELLULAR CARCINOMA,NCT02799212,Phase 3,0.1933876173035788,0.8066123826964211
CNCC[C@@H](Oc1ccccc1C)c1ccccc1,_ATOMOXETINE,"OBESITY, MORBID",NCT03460210,,0.19047783856895445,0.8095221614310456
CC(=O)Nc1nnc(S(N)(=O)=O)s1,_ACETAZOLAMIDE,"HYPERTENSION, PULMONARY",NCT02755298,Phase 2|Phase 3,0.4303639307908032,0.5696360692091967
CC12CC3CC(C)(C1)CC(N)(C3)C2,_MEMANTINE,COGNITION DISORDERS,NCT03342443,Phase 2|Phase 3,0.011785421667035731,0.9882145783329642
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,POSTOPERATIVE DELIRIUM,NCT04483596,,0.11379468812594586,0.8862053118740542
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,DELIRIUM IN OLD AGE,NCT04187807,Not Applicable,0.03241082051776488,0.9675891794822354
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,RELAPSING REMITTING MULTIPLE SCLEROSIS,NCT03498131,Early Phase 1,0.035795281264577566,0.9642047187354228
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,OSTEOPENIA,NCT04233112,Early Phase 1,0.048941553950059835,0.9510584460499404
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MIGRAINE DISORDERS,NCT03597529,Phase 2,0.03605083317712441,0.963949166822876
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,DELIRIUM,NCT04456985,Not Applicable,0.2136895088217325,0.7863104911782677
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,ANEMIA,NCT04404751,Not Applicable,0.2604308696743498,0.7395691303256503
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,_AZITHROMYCIN,BACTERIAL INFECTIONS,NCT03925480,Phase 3,0.011524106905543762,0.9884758930944564
NC(=O)c1cccnc1,_NICOTINAMIDE,PARKINSON'S DISEASE,NCT03568968,Not Applicable,0.10378880596949212,0.8962111940305083
NC(=O)c1cccnc1,_NICOTINAMIDE,HYPERTENSION,NCT04112043,Phase 1,0.1801586262737711,0.8198413737262287
NC(=O)c1cccnc1,_NIACINAMIDE,PARKINSON'S DISEASE,NCT03568968,Not Applicable,0.10378880596949212,0.8962111940305083
NC(=O)c1cccnc1,_NIACINAMIDE,HYPERTENSION,NCT04112043,Phase 1,0.1801586262737711,0.8198413737262287
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,OVARIAN CANCER,NCT03924882,Phase 2,0.4025691584205545,0.5974308415794453
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,SOFT TISSUE SARCOMA,NCT03890068,Phase 2,0.4544118114381186,0.5455881885618814
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,HEPATOCELLULAR CARCINOMA,NCT03945799,Phase 1|Phase 2,0.4244768803735831,0.5755231196264169
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,GASTROINTESTINAL STROMAL TUMORS,NCT04106024,Phase 2,0.483147963035689,0.516852036964311
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,BURN,NCT00985205,Phase 3,0.16043939594051285,0.8395606040594872
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,BURN,NCT00985205,Phase 3,0.16043939594051285,0.8395606040594872
[F-].[Na+],_SODIUM_FLUORIDE,CAROTID ARTERY STENOSIS,NCT03353103,Phase 2,0.03893981157800433,0.9610601884219956
CNC[C@H](O)c1cccc(O)c1,_PHENYLEPHRINE,"STRESS DISORDERS, POST-TRAUMATIC",NCT02560805,Phase 2,0.509240399947064,0.4907596000529358
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,SEPSIS,NCT04160676,Not Applicable,0.07984269479713597,0.920157305202864
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,_AZACITIDINE,HEAD AND NECK CANCER,NCT03019003,Phase 1|Phase 2,0.8591256758599423,0.14087432414005802
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,BREAST CANCER,NCT02790580,Phase 2,0.2491935531706677,0.7508064468293321
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,OSTEOSARCOMA,NCT03900793,Phase 1,0.33329834859548463,0.6667016514045152
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,GASTROINTESTINAL STROMAL TUMORS,NCT03673501,Phase 3,0.2723809228581763,0.7276190771418236
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,MALARIA,NCT04456634,Phase 1,0.6059710845691442,0.3940289154308561
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS,NCT02953184,Phase 2,0.06789564677391906,0.9321043532260812
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,METASTATIC BREAST CANCER,NCT04159818,Phase 2,0.06467700976563373,0.9353229902343664
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,_DOXORUBICIN_HYDROCHLORIDE,OVARIAN CANCER,NCT04337632,Phase 3,0.186615949697334,0.8133840503026663
O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,_ZOLEDRONIC_ACID,"OSTEOARTHRITIS, HIP",NCT04303026,Phase 3,0.005608537319423936,0.994391462680576
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,"OBESITY, MORBID",NCT03440190,,0.10899268137743284,0.8910073186225673
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,ANXIETY,NCT02153944,Not Applicable,0.08307312676800803,0.916926873231992
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,OSTEOPOROSIS,NCT04550078,Not Applicable,0.11362331247684715,0.8863766875231529
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O,_CALCIFEDIOL,MYOCARDIAL INFARCTION,NCT02548364,Phase 3,0.06615328548199599,0.9338467145180042
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03953261,Phase 2,0.1184581077379447,0.8815418922620555
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,PROSTATE CANCER,NCT03769766,Phase 3,0.12246749508972338,0.8775325049102767
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,BREAST CANCER,NCT03980509,Phase 1,0.25888387911842875,0.7411161208815712
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,ULCERATIVE COLITIS,NCT02277223,Phase 3,0.11642087772185498,0.8835791222781453
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,"HEMATOMA, SUBDURAL, CHRONIC",NCT03845322,Early Phase 1,0.1184581077379447,0.8815418922620555
CN(CC(=O)O)C(=N)N,_CREATINE,KNEE OSTEOARTHRITIS,NCT04423432,Not Applicable,0.4800075963743471,0.5199924036256529
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,SPINAL CORD INJURIES,NCT02323698,Phase 1|Phase 2,0.09115584830669414,0.9088441516933058
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,HIV INFECTION,NCT04425902,Phase 1,0.1989342986785501,0.8010657013214499
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,CATARACT,NCT03534973,Not Applicable,0.03622546061518521,0.9637745393848148
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,"PAIN, POSTOPERATIVE",NCT04280263,Not Applicable,0.03721607326340655,0.9627839267365934
Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,_VITAMIN_E,BREAST CANCER,NCT04463459,Not Applicable,0.21155744470730428,0.7884425552926959
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,ATOPIC DERMATITIS,NCT02537509,Phase 2,0.12205435581796255,0.8779456441820376
CN(C)C(=N)NC(=N)N,_METFORMIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.08465628461859367,0.9153437153814064
CN(C)C(=N)NC(=N)N,_METFORMIN,BREAST CANCER,NCT04559308,Phase 2,0.0132334890711993,0.9867665109288009
CN(C)C(=N)NC(=N)N,_METFORMIN,PRIMARY OPEN ANGLE GLAUCOMA,NCT04155164,Not Applicable,0.004884197273945224,0.9951158027260548
CN(C)C(=N)NC(=N)N,_METFORMIN,HEART FAILURE,NCT03331861,Phase 2,0.00889358462572388,0.991106415374276
CN(C)C(=N)NC(=N)N,_METFORMIN,RHEUMATOID ARTHRITIS,NCT04068246,Early Phase 1,0.00889358462572388,0.991106415374276
CN(C)C(=N)NC(=N)N,_METFORMIN,RHEUMATOID ARTHRITIS|CARDIOVASCULAR DISEASES,NCT02246257,Not Applicable,0.00889358462572388,0.991106415374276
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NEOPLASMS,NCT02964013,Phase 1,0.32390495314242984,0.6760950468575697
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.06086623299439356,0.9391337670056066
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,CAROTID ARTERY STENOSIS,NCT02677545,Phase 2,0.0234751183986904,0.9765248816013096
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,SEPSIS,NCT01784159,Phase 2,0.021238348828679362,0.9787616511713206
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.03057994343695565,0.9694200565630444
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,LIVER TRANSPLANT; COMPLICATIONS,NCT04327427,,0.08355196231698171,0.9164480376830184
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,OVARIAN CANCER,NCT03378297,Early Phase 1,0.06086623299439356,0.9391337670056066
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,CAROTID ARTERY STENOSIS,NCT02677545,Phase 2,0.0234751183986904,0.9765248816013096
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,SEPSIS,NCT01784159,Phase 2,0.021238348828679362,0.9787616511713206
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.03057994343695565,0.9694200565630444
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,LIVER TRANSPLANT; COMPLICATIONS,NCT04327427,,0.08355196231698171,0.9164480376830184
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,_MORPHINE,CESAREAN SECTION,NCT03427463,Early Phase 1,0.009009387351778655,0.9909906126482212
NC(N)=O,_UREA,HELICOBACTER PYLORI INFECTION,NCT04233684,Not Applicable,0.29150245547980885,0.7084975445201909
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,_PENTOXIFYLLINE,SCHIZOPHRENIA,NCT04094207,Phase 1|Phase 2,0.10167730996916717,0.8983226900308326
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,BREAST CANCER,NCT02958852,Phase 2,0.07994276623425649,0.9200572337657436
CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,_VALSARTAN,"OBESITY, MORBID",NCT03535376,,0.2177971420847533,0.7822028579152467
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,BREAST CANCER,NCT02897700,Phase 1,0.11736278560210375,0.8826372143978963
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,_PRAVASTATIN,HIV INFECTION,NCT04425902,Phase 1,0.3921097930823183,0.6078902069176816
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,HIV INFECTION,NCT04425902,Phase 1,0.21137466641429772,0.7886253335857021
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,"OBESITY, MORBID",NCT03519906,,0.15467058112749468,0.845329418872505
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,HIV INFECTION,NCT04425902,Phase 1,0.09302956189818293,0.9069704381018171
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,_DIGOXIN,HIV INFECTION,NCT04425902,Phase 1,0.5637486497064317,0.4362513502935684
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,_DIGOXIN,ACTINIC KERATOSIS,NCT03684772,Phase 2,0.3557462167722178,0.6442537832277823
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,HIV INFECTION,NCT04425902,Phase 1,0.246240760071894,0.7537592399281056
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,RHEUMATOID ARTHRITIS,NCT03770923,Phase 3,0.0585886704229472,0.9414113295770528
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,PAIN,NCT02793375,Phase 3,0.09256853110677764,0.9074314688932223
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,BREAST CANCER,NCT04172220,Not Applicable,0.022118143249349083,0.9778818567506509
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,HIV INFECTION,NCT04425902,Phase 1,0.10350223083164824,0.8964977691683517
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,FATIGUE,NCT04141696,Phase 1|Phase 2,0.060316466855960524,0.9396835331440396
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,OVARIAN CANCER,NCT03532139,Phase 2,0.18135432468623347,0.8186456753137666
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,RHEUMATOID ARTHRITIS|CARDIOVASCULAR DISEASES,NCT02246257,Not Applicable,0.133620277656312,0.8663797223436882
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,"OBESITY, MORBID",NCT03440177,,0.2024396096183557,0.7975603903816443
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,MYOCARDIAL INFARCTION,NCT03715998,Phase 2,0.21345941430930607,0.7865405856906935
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,_BUPROPION,WILSON DISEASE,NCT04526210,Phase 1,0.06698922027620174,0.9330107797237982
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,_HALOPERIDOL,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.18158811305564956,0.8184118869443505
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,_ESMOLOL,DIABETIC FOOT ULCER,NCT03998436,Phase 3,0.17331613559771242,0.8266838644022875
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,ANTERIOR CRUCIATE LIGAMENT INJURY,NCT03818932,Phase 2|Phase 3,0.0003159677607756102,0.9996840322392244
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,ANALGESIA,NCT03974932,Phase 3,0.11627419555963538,0.8837258044403646
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,WILSON DISEASE,NCT04526197,Phase 1,0.0038369464749712454,0.9961630535250288
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,"STRESS DISORDERS, POST-TRAUMATIC",NCT02560805,Phase 2,0.2902868584817862,0.7097131415182139
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,OSTEOSARCOMA,NCT03900793,Phase 1,0.3742410827914365,0.6257589172085634
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,RHEUMATOID ARTHRITIS|CARDIOVASCULAR DISEASES,NCT02246257,Not Applicable,0.2611772618170483,0.7388227381829519
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,"OBESITY, MORBID",NCT03519893,,0.3001417213699875,0.6998582786300125
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,_COBIMETINIB,METASTATIC MELANOMA,NCT04109456,Phase 1,0.7306724893266983,0.2693275106733016
Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,_PANOBINOSTAT,HIV INFECTION,NCT02471430,Phase 1|Phase 2,0.5758947104920488,0.4241052895079512
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.5197197143350695,0.4802802856649305
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,METASTATIC MELANOMA,NCT02392871,Phase 1|Phase 2,0.8200796769503711,0.17992032304962893
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.5308341102678095,0.4691658897321906
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,METASTATIC MELANOMA,NCT02392871,Phase 1|Phase 2,0.8666644838893326,0.13333551611066738
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,BREAST CANCER,NCT03168074,Phase 2,0.782479153221653,0.21752084677834735
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,OSTEOSARCOMA,NCT04154189,Phase 2,0.5179521645939927,0.4820478354060072
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BREAST NEOPLASM,NCT03280563,Phase 1|Phase 2,0.4063657457400987,0.5936342542599014
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,PROSTATE CANCER,NCT03706365,Phase 2,0.3722688376470916,0.6277311623529084
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BREAST CANCER,NCT04565054,Phase 3,0.3740962315513029,0.625903768448697
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,BREAST CANCER,NCT04170465,Phase 2,0.3063367891526998,0.6936632108473
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,HEART FAILURE,NCT03331861,Phase 2,0.28837812507396776,0.7116218749260326
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,PROSTATE CANCER,NCT02643667,Phase 1|Phase 2,0.7646492042263521,0.23535079577364834
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,NON-HODGKIN'S LYMPHOMA,NCT03198026,Phase 2,0.7439367294219916,0.256063270578009
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,BREAST NEOPLASM,NCT03295552,Phase 2,0.6810432568217497,0.31895674317825057
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.007355779104355975,0.992644220895644
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,INFERTILITY,NCT03824340,Not Applicable,0.04069626925687695,0.959303730743123
C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O,_CARBIDOPA,SPINAL CORD INJURIES,NCT04520178,Phase 2|Phase 3,0.1438869900099775,0.8561130099900224
CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,_TOPIRAMATE,SCHIZOPHRENIA,NCT02808533,Not Applicable,0.05161004155985223,0.9483899584401476
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,_EXENATIDE,PARKINSON'S DISEASE,NCT04305002,Phase 2,0.23590383443196825,0.7640961655680316
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,_EXENATIDE,SMOKING CESSATION,NCT02975297,Phase 1|Phase 2,0.23270272002758235,0.7672972799724175
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,_DICLOFENAC,BREAST CANCER,NCT04511832,Not Applicable,0.07594911715341268,0.9240508828465872
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,_BUPRENORPHINE,"OBESITY, MORBID",NCT03460314,,0.06441351813669845,0.9355864818633016
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,_BUPRENORPHINE,MAJOR DEPRESSIVE DISORDER,NCT04116528,Phase 3,0.020494448176912955,0.9795055518230872
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,ACUTE PAIN DUE TO TRAUMA,NCT04133623,Phase 3,0.0043930528875273395,0.9956069471124728
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,ANALGESIA,NCT03955211,Phase 2,0.16790414071262788,0.8320958592873718
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,MUSCULOSKELETAL INJURY,NCT03767933,Phase 2,0.0001001592179805235,0.9998998407820197
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,"OBESITY, MORBID",NCT03476577,,0.1253433001843599,0.8746566998156401
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,_CIPROFLOXACIN,PNEUMONIA,NCT03177720,Phase 1,0.018633283580361617,0.9813667164196384
CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,_CLOBETASOL_PROPIONATE,CATARACT,NCT04249076,Phase 3,0.014065968400143044,0.9859340315998568
CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,_CLOBETASOL_PROPIONATE,ORAL LICHEN PLANUS,NCT04364555,Phase 2|Phase 3,0.02210370920911283,0.9778962907908872
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,_CLOBETASOL,CATARACT,NCT04249076,Phase 3,0.015368602764227472,0.9846313972357724
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,_CLOBETASOL,ORAL LICHEN PLANUS,NCT04364555,Phase 2|Phase 3,0.01255226417409835,0.9874477358259016
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,INFECTION,NCT03844776,Not Applicable,0.047983435962939615,0.9520165640370606
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,PERIODONTITIS,NCT03733379,Phase 3,0.007717491938396733,0.9922825080616032
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,TRAUMATIC BRAIN INJURY,NCT04058132,Phase 2,0.15702323606576502,0.8429767639342347
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,MAJOR DEPRESSIVE DISORDER,NCT04344678,Not Applicable,0.06930882064526399,0.930691179354736
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,GLAUCOMA,NCT04052269,Phase 3,0.12418383351899485,0.8758161664810054
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,BIRTH ASPHYXIA,NCT04169191,Phase 1,0.06823853077570206,0.931761469224298
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,BRONCHOPULMONARY DYSPLASIA,NCT03142568,Phase 2,0.1227732131338429,0.8772267868661571
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,_SILDENAFIL_CITRATE,TRAUMATIC BRAIN INJURY,NCT04058132,Phase 2,0.5210095293951696,0.4789904706048304
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,_SILDENAFIL_CITRATE,MAJOR DEPRESSIVE DISORDER,NCT04344678,Not Applicable,0.5738124674994733,0.42618753250052704
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,_SILDENAFIL_CITRATE,BIRTH ASPHYXIA,NCT04169191,Phase 1,0.46158226126962104,0.538417738730379
COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,_APIXABAN,"OBESITY, MORBID",NCT03448783,,0.3034373743506513,0.6965626256493487
CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O,_CALCITONIN,MIGRAINE DISORDERS,NCT04019496,,0.25164005207711226,0.7483599479228874
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_CHLOROQUINE,ATRIAL FIBRILLATION,NCT02932007,Phase 2,0.10747867069804716,0.8925213293019528
CC[C@@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,_IVERMECTIN,MALARIA,NCT03967054,Phase 3,0.020202492279277885,0.9797975077207224
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,PARKINSON'S DISEASE,NCT04342273,Phase 1,0.17403989526532412,0.8259601047346757
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,SCHIZOPHRENIA,NCT04369391,Phase 1,0.20857548523694505,0.791424514763055
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,DIABETES,NCT01984827,Phase 1,0.19574217818157907,0.8042578218184208
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,PNEUMONIA,NCT03177720,Phase 1,0.18952628891481965,0.8104737110851804
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,_ROFLUMILAST,ASTHMA,NCT04108377,Phase 1,0.5617317385400897,0.4382682614599103
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,_ROFLUMILAST,CHRONIC PLAQUE PSORIASIS,NCT04286607,Phase 3,0.5343767409512784,0.4656232590487216
O=C(O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1,_TETRAC,POST-DURAL PUNCTURE HEADACHE,NCT02813655,Phase 2,0.11539373816220833,0.8846062618377916
Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,_CEFAZOLIN,BREAST NEOPLASM,NCT03742908,Not Applicable,0.019834793011848442,0.9801652069881516
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.024394483350743342,0.9756055166492564
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,INFECTION,NCT03844776,Not Applicable,0.061791216642752174,0.9382087833572476
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,PERIODONTITIS,NCT03733379,Phase 3,0.024394483350743342,0.9756055166492564
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,BACTERIAL VAGINOSES,NCT03954990,Phase 1,0.059591716241901974,0.940408283758098
COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,_VENLAFAXINE,"OBESITY, MORBID",NCT03532477,,0.11122104672471557,0.8887789532752843
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,_FLUOXETINE,TYPE 1 DIABETES,NCT03228732,Early Phase 1,0.05074786041744757,0.9492521395825526
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,_FLUOXETINE,"OBESITY, MORBID",NCT03476525,,0.07436524466998701,0.9256347553300128
CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,_DULOXETINE,OSTEO ARTHRITIS OF THE KNEES,NCT04224584,Phase 2,0.006257950181629461,0.9937420498183706
CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,_DULOXETINE,ACUTE PAIN,NCT03549026,Not Applicable,0.0065414564993976215,0.9934585435006024
CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,_ESCITALOPRAM,"OBESITY, MORBID",NCT03460379,,0.1630083141311335,0.8369916858688664
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,_BREXPIPRAZOLE,SCHIZOPHRENIA,NCT03874494,Phase 3,0.8525294260967763,0.14747057390322366
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,_BREXPIPRAZOLE,BORDERLINE PERSONALITY DISORDER,NCT04100096,Phase 2,0.8620394845396774,0.13796051546032256
NCC1(CC(=O)O)CCCCC1,_GABAPENTIN,ANTERIOR CRUCIATE LIGAMENT INJURY,NCT03818932,Phase 2|Phase 3,0.0001001592179805235,0.9998998407820197
NCC1(CC(=O)O)CCCCC1,_GABAPENTIN,"OBESITY, MORBID",NCT03476538,,0.06870494058310445,0.9312950594168956
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,_ERTAPENEM,URINARY TRACT INFECTIONS,NCT03218800,Phase 3,0.2276447983675164,0.7723552016324834
Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,_LAMOTRIGINE,"OBESITY, MORBID",NCT03497143,,0.09955351842621024,0.9004464815737897
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,HYPERTENSION,NCT02133872,Phase 1,0.12052237321025612,0.8794776267897437
CC(C)C[C@H](CN)CC(=O)O,_PREGABALIN,NAUSEA,NCT04181346,Phase 2,0.003389392174002085,0.996610607825998
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,_CAPSAICIN,PARKINSON'S DISEASE,NCT03321019,,0.15975650514827802,0.8402434948517221
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,_CAPSAICIN,SPINAL CORD INJURIES|NEUROPATHIC PAIN,NCT02441660,Not Applicable,0.07195298222526841,0.9280470177747318
NS(=O)(=O)Cc1noc2ccccc12,_ZONISAMIDE,PARKINSON'S DISEASE,NCT04182399,Not Applicable,0.14782715162063242,0.8521728483793676
CC[C@@H](C(N)=O)N1CCCC1=O,_LEVETIRACETAM,SCHIZOPHRENIA,NCT02647437,Not Applicable,0.03501482128783709,0.9649851787121628
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,_RISPERIDONE,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.16324518402441868,0.8367548159755812
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,_ARIPIPRAZOLE,TOURETTE SYNDROME,NCT03487783,Phase 3,0.13383554112621948,0.8661644588737808
Cc1nc2n(c(=O)c1CCN1CCC(C3NOc4cc(F)ccc43)CC1)CCCC2,_RISPERIDON,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.1904118030808317,0.8095881969191684
CC(C)Cn1cnc2c(N)nc3ccccc3c21,_IMIQUIMOD,METASTATIC BREAST CANCER,NCT03982004,Phase 1,0.16169537292408445,0.8383046270759154
CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,_TERBINAFINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.10608504178963807,0.8939149582103618
N[C@@H]1CONC1=O,_CYCLOSERINE,MAJOR DEPRESSIVE DISORDER,NCT03511599,Phase 1,0.17619885600180088,0.8238011439981989
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,ANALGESIA,NCT04442906,Not Applicable,0.006880937245621543,0.9931190627543784
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,POSTOPERATIVE DELIRIUM,NCT03120442,Not Applicable,0.004009387351778656,0.9959906126482212
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,PRURITIS,NCT04518618,Not Applicable,0.01423671634997752,0.9857632836500224
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,_ONDANSETRON,JUVENILE IDIOPATHIC ARTHRITIS,NCT04169828,Not Applicable,0.01423671634997752,0.9857632836500224
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,FATIGUE,NCT04141696,Phase 1|Phase 2,0.037244887680763915,0.9627551123192362
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,POST-TRAUMATIC STRESS DISORDER,NCT03960658,Phase 1|Phase 2,0.15198223308535475,0.8480177669146451
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,TINNITUS,NCT03336398,Phase 2,0.015533494257322415,0.9844665057426776
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,SUBARACHNOID HEMORRHAGE,NCT02636218,Phase 2|Phase 3,0.029289322410502163,0.970710677589498
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,ANALGESIA,NCT03922048,Phase 2,0.023682301254430427,0.9763176987455696
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.0008415430882505443,0.9991584569117496
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,POSTOPERATIVE DELIRIUM,NCT03120442,Not Applicable,0.0048509304400292,0.9951490695599708
CNC[C@H](O)c1ccc(O)c(O)c1,_EPINEPHRINE,SCAR,NCT02234193,Early Phase 1,0.02485550188772601,0.975144498112274
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,_OXYCODONE,PARKINSON'S DISEASE,NCT02601586,Phase 2|Phase 3,0.02254023538383973,0.9774597646161602
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,_OXYCODONE,SPINAL CORD INJURIES,NCT03906721,Phase 2,0.02105709134318461,0.9789429086568154
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,_DIAZEPAM,CONTRACEPTION,NCT02799641,Not Applicable,0.06613395947957718,0.9338660405204229
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,_DIAZEPAM,ANTERIOR CRUCIATE LIGAMENT INJURY,NCT03818932,Phase 2|Phase 3,0.05708782987930078,0.9429121701206994
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,OBESITY,NCT03866408,Early Phase 1,0.09085323302583607,0.909146766974164
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,GASTROPARESIS,NCT04300127,Early Phase 1,0.1750384955352155,0.8249615044647846
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,_TIMOLOL,PRIMARY OPEN ANGLE GLAUCOMA,NCT03193333,Phase 3,0.21811139679276,0.7818886032072403
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,OBESITY,NCT03043053,Phase 2,0.09657317712612226,0.9034268228738777
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,TINNITUS,NCT04210310,Not Applicable,0.14502800445503866,0.8549719955449611
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,POSTOPERATIVE PAIN,NCT03011307,Phase 2,0.14502800445503866,0.8549719955449611
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,NEUROPATHIC PAIN,NCT02100956,Phase 2,0.1590031485554111,0.8409968514445886
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,BORDERLINE PERSONALITY DISORDER,NCT02225600,Not Applicable,0.10732093900826233,0.8926790609917375
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,PROSTATE CANCER,NCT03808077,Phase 2,0.13444459843346535,0.8655554015665347
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5,_HYDROMORPHONE,MUSCULOSKELETAL INJURY,NCT03767933,Phase 2,0.01489685201266174,0.9851031479873384
COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,_HYDROCODONE,ANTERIOR CRUCIATE LIGAMENT INJURY,NCT03818932,Phase 2|Phase 3,0.013674001162618816,0.9863259988373811
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,_NALBUPHINE,POSTOPERATIVE COMPLICATIONS,NCT03470077,Phase 2,0.05468791265848398,0.945312087341516
CCCN[C@H]1CCc2nc(N)sc2C1,_PRAMIPEXOLE,CHRONIC PAIN,NCT03842709,Early Phase 1,0.05288186833801303,0.9471181316619868
CCN(CC)C(=O)C1(c2ccccc2)CC1CN,_MILNACIPRAN,DEPRESSION,NCT02783430,Phase 2|Phase 3,0.02944826788140525,0.9705517321185948
CCN(CC)C(=O)C1(c2ccccc2)CC1CN,_MILNACIPRAN,NEUROPATHIC PAIN,NCT01914042,Phase 2,0.02944826788140525,0.9705517321185948
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,PAIN,NCT04034004,Early Phase 1,0.11996495785403148,0.8800350421459686
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,PRURITIS,NCT04518618,Not Applicable,0.08777925685339176,0.9122207431466084
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,EPILEPSY,NCT02332447,Phase 3,0.09317980856328008,0.90682019143672
CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,_IOHEXOL,ACUTE KIDNEY INJURY,NCT02772276,Phase 2,0.2564168659505515,0.7435831340494482
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,BURN,NCT03513406,Phase 3,0.06844372756087004,0.93155627243913
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,POSTOPERATIVE PAIN,NCT04544228,Not Applicable,0.08048685698381046,0.9195131430161896
COc1cc(CC(C)N)c(OC)cc1C,_DOM,STROKE,NCT03828851,Not Applicable,0.185874951628136,0.8141250483718642
COc1cc(CC(C)N)c(OC)cc1C,_DOM,GASTROPARESIS,NCT03810287,Early Phase 1,0.2745159102455074,0.7254840897544926
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,"HEMATOMA, SUBDURAL, CHRONIC",NCT03582293,Phase 3,0.0011912516549553134,0.9988087483450449
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,EPISTAXIS,NCT02930941,Not Applicable,0.0011912516549553134,0.9988087483450449
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,_VANDETANIB,NEOPLASMS,NCT02530411,Phase 2,0.9028008735859268,0.09719912641407284
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,_HYDROCHLOROTHIAZIDE,"OBESITY, MORBID",NCT03476551,,0.30075185553898154,0.6992481444610182
[Cl-].[K+],_POTASSIUM_CHLORIDE,HEART FAILURE,NCT02840799,Phase 2,0.09043909279574387,0.9095609072042562
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,_BROMOCRIPTINE,OBESITY,NCT03525002,Phase 2,0.2235608360758869,0.7764391639241132
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,_LAPATINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.8100618951424869,0.18993810485751306
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,_CRIZOTINIB,NEOPLASMS,NCT03194893,Phase 3,0.6734790670816679,0.32652093291833234
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.14641516557868206,0.8535848344213179
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEAD AND NECK CANCER,NCT03654612,Phase 1|Phase 2,0.14641516557868206,0.8535848344213179
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.14641516557868206,0.8535848344213179
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEAD AND NECK CANCER,NCT03654612,Phase 1|Phase 2,0.14641516557868206,0.8535848344213179
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,METASTATIC BREAST CANCER,NCT02362230,Phase 2,0.5202489777664765,0.4797510222335234
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,OVARIAN CANCER,NCT03763123,Phase 1,0.7670529509486795,0.2329470490513204
CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,_ATENOLOL,"STRESS DISORDERS, POST-TRAUMATIC",NCT02560805,Phase 2,0.14197416358568987,0.8580258364143101
Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,_TALAZOPARIB,BREAST CANCER,NCT04039230,Phase 1|Phase 2,0.8481637939912645,0.1518362060087355
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,TYPE 1 DIABETES,NCT04201496,Phase 1,0.4625246244441937,0.5374753755558062
Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,_MARAVIROC,STROKE,NCT03172026,Phase 2|Phase 3,0.4701296232598679,0.5298703767401322
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,PARKINSON'S DISEASE,NCT04164758,Phase 2,0.02976658109555403,0.9702334189044459
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,"OBESITY, MORBID",NCT03449472,,0.1588155724507642,0.8411844275492357
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,POST TRAUMATIC STRESS DISORDER,NCT04280965,Early Phase 1,0.02741598110669222,0.9725840188933076
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,POSTOPERATIVE DELIRIUM,NCT03739476,Phase 3,0.0360685381183931,0.9639314618816068
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,_CLOPIDOGREL,CAROTID ARTERY STENOSIS,NCT02677545,Phase 2,0.03393697681212533,0.9660630231878744
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,_CLOPIDOGREL,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.030225868278055113,0.9697741317219449
OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,_LACTOSE,BORDERLINE PERSONALITY DISORDER,NCT02097706,Phase 2,0.2743572041980303,0.7256427958019699
OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,_LACTOSE,FRACTURES,NCT02999022,Phase 2,0.2995097989827199,0.7004902010172802
NCCCC[C@H](N)C(=O)O,_LYSINE,HEART FAILURE,NCT03446651,Early Phase 1,0.3519949012605613,0.6480050987394383
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,_PYROTINIB,METASTATIC BREAST CANCER,NCT04034589,Phase 2,0.5369607161270615,0.4630392838729386
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1,_PIRARUBICIN,SOFT TISSUE SARCOMA,NCT04126811,Phase 2,0.15684375514420726,0.8431562448557928
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,_DOBUTAMINE,MYOCARDIAL INFARCTION,NCT03289728,Not Applicable,0.17542522979306194,0.8245747702069381
CN1CCN2c3ncccc3Cc3ccccc3C2C1,_MIRTAZAPINE,BREAST CANCER,NCT02336750,Phase 3,0.0625019399731679,0.937498060026832
Brc1c(NC2=NCCN2)ccc2nccnc12,_BRIMONIDINE,PRIMARY OPEN ANGLE GLAUCOMA,NCT03193333,Phase 3,0.041001952432283835,0.9589980475677164
CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,_TREPROSTINIL,DIABETIC FOOT ULCER,NCT03654989,Phase 1|Phase 2,0.4566521024437442,0.5433478975562557
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,_EPLERENONE,HIV INFECTION,NCT02740179,Not Applicable,0.4539175397390501,0.5460824602609498
CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],_METHYLENE_BLUE,ABSCESS,NCT02240498,Phase 1,0.17638877886209753,0.8236112211379026
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,_FUROSEMIDE,ACTINIC KERATOSIS,NCT03684772,Phase 2,0.20619350703314093,0.793806492966859
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.16355869338419404,0.8364413066158061
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,ISCHEMIA REPERFUSION INJURY,NCT03663543,Phase 1|Phase 2,0.38392382673772457,0.6160761732622754
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,HAND OSTEOARTHRITIS,NCT04036929,Not Applicable,0.15734890171256893,0.8426510982874312
Cc1cc(Nc2ncc(Cl)c(=Nc3ccccc3S(=O)(=O)C(C)C)[nH]2)c(OC(C)C)cc1C1CCNCC1,_CERITINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.590974280226688,0.4090257197733119
COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,_TIVOZANIB,HEPATOCELLULAR CARCINOMA,NCT03970616,Phase 1|Phase 2,0.7457949377428212,0.2542050622571786
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,_ALPRAZOLAM,TYPE 1 DIABETES,NCT03635437,Phase 1|Phase 2,0.09770896009748124,0.9022910399025188
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,BREAST CANCER,NCT02395614,Not Applicable,0.06262309079598162,0.9373769092040184
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,INFECTION,NCT03844776,Not Applicable,0.03737494290062094,0.962625057099379
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,DIABETIC FOOT ULCER,NCT03503370,Phase 2,0.05829373059090327,0.9417062694090969
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,PRETERM PREMATURE RUPTURE OF MEMBRANE,NCT04516226,Not Applicable,0.02246205148921819,0.9775379485107816
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_CHLORHEXIDINE_GLUCONATE,PRETERM PREMATURE RUPTURE OF MEMBRANE,NCT04516226,Not Applicable,0.04761284285428826,0.9523871571457116
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_MANNITOL,SUBARACHNOID HEMORRHAGE,NCT04135456,Not Applicable,0.09001170476742483,0.9099882952325752
COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4,_TRABECTEDIN,SOFT TISSUE SARCOMA,NCT02367924,,0.7344761296927357,0.26552387030726426
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O,_CALCIPOTRIENE,BREAST CANCER,NCT03596073,Phase 1,0.04663079904881985,0.9533692009511802
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O,_CALCIPOTRIOL,BREAST CANCER,NCT03596073,Phase 1,0.04663079904881985,0.9533692009511802
[N-]=[N+]=O,_NITROUS_OXIDE,ABSCESS,NCT03127371,Not Applicable,0.06906869169516469,0.9309313083048352
CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-].[Na+],_SODIUM_TETRADECYL_SULFATE,VENOUS INSUFFICIENCY,NCT03311269,Phase 2,0.5299596136393031,0.4700403863606969
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,_DRONABINOL,OSTEO ARTHRITIS OF THE KNEES,NCT04298528,Phase 3,0.08300721437151072,0.9169927856284894
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,_DRONABINOL,CHRONIC PAIN,NCT03766269,Phase 2,0.1682849408478754,0.8317150591521245
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,_PREGNENOLONE,POST TRAUMATIC STRESS DISORDER,NCT03799562,Phase 2,0.6554835042470144,0.3445164957529856
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,_PREGNENOLONE,MAJOR DEPRESSIVE DISORDER,NCT03645096,Phase 1,0.5503886175222477,0.4496113824777525
Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1,_RUPATADINE,RHEUMATOID ARTHRITIS,NCT03770923,Phase 3,0.7380803793712957,0.2619196206287045
CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21,_NABILONE,PARKINSON'S DISEASE,NCT03773796,Phase 3,0.19608185157467994,0.8039181484253198
COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O,_COENZYME_Q1,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.6442106418371845,0.35578935816281565
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,PARKINSON'S DISEASE,NCT03575195,Phase 1|Phase 2,0.2286866415280673,0.7713133584719326
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,TYPE 2 DIABETES,NCT03758144,Not Applicable,0.20368664152806729,0.7963133584719325
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,PAPULOPUSTULAR ROSACEA,NCT03864978,Phase 2,0.2603863400800345,0.7396136599199654
CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1,_ALITRETINOIN,HAND ECZEMA,NCT03026946,Phase 3,0.03657304221038345,0.9634269577896168
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,_BOSUTINIB,DEMENTIA WITH LEWY BODIES,NCT03888222,Phase 2,0.61796722392884,0.3820327760711602
Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,_LEFLUNOMIDE,POLYMYALGIA RHEUMATICA,NCT03576794,Phase 3,0.044712472376931114,0.9552875276230688
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O,_RUXOLITINIB_PHOSPHATE,MALARIA,NCT04456634,Phase 1,0.5163472566287325,0.4836527433712675
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.23327525368304936,0.7667247463169506
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,DEMENTIA WITH LEWY BODIES,NCT04002674,Phase 2,0.3861706907972378,0.6138293092027621
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,HUNTINGTON'S DISEASE,NCT03764215,Phase 1,0.371796458798028,0.6282035412019719
CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,_RUCAPARIB,BREAST CANCER,NCT03911453,Early Phase 1,0.6250198847711232,0.374980115228877
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,_ZAFIRLUKAST,OVARIAN CANCER,NCT04339140,Phase 2,0.6440217759743727,0.3559782240256273
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,_TOFACITINIB,JUVENILE IDIOPATHIC ARTHRITIS,NCT01500551,Phase 3,0.143180263337999,0.8568197366620012
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,_TOFACITINIB,PSORIATIC ARTHRITIS,NCT03486457,Phase 3,0.18460981754277064,0.8153901824572294
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,BURN,NCT03513406,Phase 3,0.09641741088996987,0.90358258911003
O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,_SOLIFENACIN,OVERACTIVE BLADDER|PARKINSON DISEASE,NCT03149809,Phase 3,0.10621486522944566,0.8937851347705542
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,_ENALAPRIL,"OBESITY, MORBID",NCT03460366,,0.1886234905143041,0.8113765094856958
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF,_FLUTICASONE,PHARMACOKINETICS,NCT03739294,Phase 2,0.14370898401542534,0.8562910159845747
[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],_FERUMOXYTOL,CORONARY ARTERY DISEASE,NCT02954510,Phase 3,0.1287150640969533,0.8712849359030466
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],_NITROGLYCERIN,HYPERTENSION,NCT02425566,Phase 1,0.5009738166653951,0.499026183334605
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],_NITROGLYCERIN,CARDIOVASCULAR DISEASE,NCT02115724,Not Applicable,0.4754249796994695,0.5245750203005306
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03843125,Phase 3,0.3056219763307629,0.6943780236692371
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,JUVENILE IDIOPATHIC ARTHRITIS,NCT03773978,Phase 3,0.30351557909285554,0.6964844209071442
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,ATOPIC DERMATITIS,NCT03952559,Phase 3,0.30351557909285554,0.6964844209071442
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,ALOPECIA AREATA,NCT03899259,Phase 3,0.3001944199048824,0.6998055800951175
N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1,_CRISABOROLE,ALOPECIA AREATA,NCT04299503,Phase 2,0.1406003634316194,0.8593996365683805
CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,_TRIAMCINOLONE_HEXACETONIDE,OSTEO ARTHRITIS OF THE KNEES,NCT04231318,Phase 3,0.17283310780341385,0.8271668921965865
C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,_OXANDROLONE,ROTATOR CUFF TEAR,NCT03091075,Phase 2,0.7834094767346736,0.21659052326532632
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,PROSTATE CANCER,NCT03716739,Phase 2,0.1664230870171438,0.8335769129828559
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,SPINAL CORD INJURIES,NCT02317640,Phase 1|Phase 2,0.1608357708027669,0.8391642291972328
CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,_TESTOSTERONE_UNDECANOATE,SPINAL CORD INJURIES,NCT03576001,Phase 2,0.33382235930364906,0.6661776406963505
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,_KETOCONAZOLE,PROSTATE CANCER,NCT00859781,Phase 2,0.26314921331759605,0.7368507866824038
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,_KETOCONAZOLE,SEBORRHEIC DERMATITIS,NCT03688971,Phase 2,0.2572181081976335,0.7427818918023664
O=C(O)c1cccnc1,_NIACIN,POST TRAUMATIC STRESS DISORDER,NCT03752918,Phase 1,0.14316511069511326,0.8568348893048868
CNC1(c2ccccc2Cl)CCCCC1=O.Cl,_KETAMINE_HYDROCHLORIDE,TINNITUS,NCT03336398,Phase 2,0.2499410726896995,0.7500589273103005
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,HEPATOCELLULAR CARCINOMA,NCT04258566,Phase 1,0.2863459327980309,0.7136540672019689
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,RHEUMATOID ARTHRITIS,NCT02680067,Phase 1,0.3343167894004733,0.6656832105995265
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,ABDOMINAL INJURIES,NCT04534816,Not Applicable,0.1664280922005509,0.8335719077994487
C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],_GLYCOPYRROLATE,BURN,NCT03513406,Phase 3,0.1835440258195007,0.8164559741804993
CC1CCC(C(C)C)C(O)C1,_MENTHOL,ACUTE PAIN,NCT04484428,Phase 2,0.2981922437897422,0.7018077562102575
CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]1O,_HYALURONATE,GLAUCOMA,NCT03758859,Not Applicable,0.34652610780925913,0.653473892190741
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,_TICAGRELOR,CAROTID ARTERY STENOSIS,NCT02677545,Phase 2,0.040495296884621945,0.959504703115378
O=[N+]([O-])[O-],_NITRATE,HEART FAILURE,NCT02840799,Phase 2,0.18573321181285107,0.8142667881871489
O=[N+]([O-])[O-],_NITRATE,ERECTILE DYSFUNCTION,NCT04116060,Not Applicable,0.13100821353544673,0.8689917864645531
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,_MIFEPRISTONE,BREAST CANCER,NCT02788981,Phase 2,0.10732044438062707,0.8926795556193728
CC(=O)C(=O)O,_PYRUVATE,PROSTATE CANCER,NCT02913131,Phase 1|Phase 2,0.3341032313872392,0.6658967686127607
CC(=O)C(=O)O,_PYRUVATE,BREAST CANCER,NCT03121989,Phase 1,0.2677634464212897,0.7322365535787101
NCC(=O)CCC(=O)O,_AMINOLEVULINIC_ACID,GENITAL WARTS,NCT03948321,Not Applicable,0.07451761427350061,0.9254823857264992
CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2,_GRANISETRON,SEPSIS,NCT03924518,Phase 2,0.18673976049951016,0.8132602395004899
C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,_LEVOSIMENDAN,ST ELEVATION MYOCARDIAL INFARCTION,NCT03699215,Phase 3,0.05889536975504114,0.9411046302449588
Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,_OXYMETAZOLINE,FECAL INCONTINENCE,NCT03529487,Phase 1,0.10718753973517757,0.8928124602648224
COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,_GLYBURIDE,ACUTE SPINAL CORD INJURY,NCT02524379,Phase 1|Phase 2,0.29020476046974913,0.7097952395302507
C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,_LISDEXAMFETAMINE,"OBESITY, MORBID",NCT03497169,,0.4133172699329926,0.5866827300670073
CCOC(=O)c1ccc(N)cc1,_BENZOCAINE,OBESITY,NCT02537314,Phase 1,0.1892246854855091,0.8107753145144909
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,_ILOPROST,"RESPIRATORY DISTRESS SYNDROME, ADULT",NCT03111212,Phase 3,0.18485563561447013,0.8151443643855301
CN(C)CCC=C1c2ccccc2COc2ccccc21,_DOXEPIN,BREAST CANCER,NCT02447211,Phase 2,0.05832717577659788,0.941672824223402
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,_TERAZOSIN,PARKINSON'S DISEASE,NCT03905811,Phase 1|Phase 2,0.16950902283630814,0.8304909771636918
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,_TERAZOSIN,CAROTID ARTERY STENOSIS,NCT03195673,Phase 2,0.1533711853783724,0.8466288146216274
N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,_VILDAGLIPTIN,MAJOR DEPRESSIVE DISORDER,NCT04410341,Phase 1|Phase 2,0.12983925652093453,0.8701607434790654
O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,_DOMPERIDONE,GASTROPARESIS,NCT03810287,Early Phase 1,0.277818887044968,0.722181112955032
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O,_ALBUTEROL_SULFATE,ASTHMA,NCT03847896,Phase 3,0.5395945718135488,0.4604054281864513
O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE_FUMARATE,POST TRAUMATIC STRESS DISORDER,NCT04280965,Early Phase 1,0.17714871769761534,0.8228512823023848
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,_PIMAVANSERIN,PARKINSON'S DISEASE,NCT04164758,Phase 2,0.2603695529642501,0.7396304470357495
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,_PIMAVANSERIN,SCHIZOPHRENIA,NCT04531982,Phase 3,0.2525124182297292,0.7474875817702704
Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,_TOMIVOSERTIB,BREAST CANCER,NCT04261218,Phase 1,0.7184721021675332,0.2815278978324667
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,_FOSTAMATINIB,OVARIAN CANCER,NCT03246074,Phase 1,0.7846664737575039,0.2153335262424964
CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,_CHLORPROTHIXENE,"OBESITY, MORBID",NCT03449485,,0.3978542977870113,0.6021457022129885
CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,_CAPMATINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.5641765474859456,0.4358234525140545
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,_SEMAGLUTIDE,TYPE 1 DIABETES,NCT03899402,Phase 2|Phase 3,0.3278766998357542,0.6721233001642459
N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,_GLUCOSAMINE,KNEE OSTEOARTHRITIS,NCT04470336,Not Applicable,0.11708056398804514,0.882919436011955
O=C(Oc1ccccc1C(=O)O)c1ccccc1O,_SALSALATE,PCOS,NCT03229408,Phase 2,0.19174310935261915,0.8082568906473806
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,PAIN,NCT04313179,Not Applicable,0.2077357933317772,0.7922642066682228
Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,_ETORICOXIB,MUSCULOSKELETAL PAIN,NCT04565600,Phase 2,0.019632721837106328,0.9803672781628936
CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,_APREMILAST,ATOPIC DERMATITIS,NCT04306965,Phase 2,0.006524106905543763,0.9934758930944559
Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,_RESVERATROL,KNEE OSTEOARTHRITIS,NCT02905799,Phase 3,0.11945110196764624,0.8805488980323537
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,PAIN,NCT04132609,Not Applicable,0.3664896178955245,0.6335103821044752
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,MAJOR DEPRESSIVE DISORDER,NCT04137367,Not Applicable,0.2433973221627163,0.7566026778372834
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,NICOTINE DEPENDENCE,NCT03325777,Not Applicable,0.4236506396598564,0.5763493603401435
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,ANXIETY,NCT04245501,Not Applicable,0.4255451547543356,0.5744548452456643
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,PTSD,NCT04228133,Not Applicable,0.2433973221627163,0.7566026778372834
N[C@H](CO)C(=O)O,_D-SERINE,SCHIZOPHRENIA,NCT03702933,,0.2788513460755334,0.7211486539244667
O=C([O-])[O-].[Li+].[Li+],_LITHIUM_CARBONATE,FRACTURES,NCT02999022,Phase 2,0.06889045943833991,0.9311095405616598
CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,_PERMETHRIN,MALARIA,NCT04102592,Not Applicable,0.14026918812855502,0.8597308118714447
CC(=O)N[C@@H]1C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC2[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)[C@H](O)[C@H]1O,_HYALURONIC_ACID,"PAIN, POSTOPERATIVE",NCT03814707,Not Applicable,0.001121320989360232,0.9988786790106396
O=[O+][O-],_OZONE,ISCHEMIC HEART DISEASE,NCT03660657,Phase 2|Phase 3,0.0958233162106122,0.9041766837893876
O=[O+][O-],_OZONE,KNEE OSTEOARTHRITIS,NCT04426721,Phase 3,0.0958233162106122,0.9041766837893876
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,_FLUTICASONE_FUROATE,PHARMACOKINETICS,NCT03739294,Phase 2,0.18520679375234014,0.8147932062476599
Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,_CANAGLIFLOZIN,HEART FAILURE,NCT04252287,Phase 3,0.3812851742330239,0.6187148257669759
Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1,_SUVOREXANT,NICOTINE DEPENDENCE,NCT03999099,Phase 1,0.06646305601157952,0.9335369439884204
Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1,_TEDIZOLID,ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS,NCT03176134,Phase 3,0.6382560897566735,0.3617439102433266
CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,_SARACATINIB,PARKINSON DISEASE PSYCHOSIS,NCT03661125,Early Phase 1,0.7480948791462957,0.2519051208537044
O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,_PIMONIDAZOLE,PROSTATE CANCER,NCT02095249,Not Applicable,0.6756480798473439,0.3243519201526564
O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,_PIMONIDAZOLE,HEAD AND NECK CANCER,NCT02414048,Phase 2,0.6926748067994553,0.3073251932005448
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,_RACLOPRIDE,MAJOR DEPRESSIVE DISORDER,NCT03026036,,0.482865260434835,0.517134739565165
O=N[O-],_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.4500136003699536,0.549986399630046
O=N[O-].[Na+],_SODIUM_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.7027495291744019,0.297250470825598
C[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,_SERLOPITANT,EPIDERMOLYSIS BULLOSA,NCT03836001,Phase 2,0.5419393917570179,0.4580606082429821
O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1,_DIQUAFOSOL,DRY EYE,NCT04548427,Phase 3,0.8343608086185824,0.1656391913814173
NC(=O)OCC(COC(N)=O)c1ccccc1,_FELBAMATE,EPILEPSY,NCT03196466,,0.3952113501964917,0.6047886498035083
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,_CARIPRAZINE,MAJOR DEPRESSIVE DISORDER,NCT03739203,Phase 3,0.414322165442712,0.585677834557288
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,_CARIPRAZINE,SCHIZOPHRENIA,NCT03817502,Phase 3,0.4043221654427119,0.5956778345572878
CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,_LASMIDITAN,MIGRAINE DISORDERS,NCT04396574,Phase 3,0.32586953188804524,0.6741304681119549
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,_ALPELISIB,BREAST CANCER,NCT03056755,Phase 2,0.5555025932866748,0.4444974067133252
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,_ERDAFITINIB,METASTATIC BREAST CANCER,NCT03238196,Phase 1,0.5657971546519956,0.4342028453480045
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12,_ERAVACYCLINE,BACTERIAL INFECTIONS,NCT03696550,Phase 1,0.3864993724860563,0.6135006275139434
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,_DAROLUTAMIDE,PROSTATE CANCER,NCT04136353,Phase 3,0.4506652479507999,0.5493347520492001
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ATOPIC DERMATITIS,NCT03569293,Phase 3,0.4306973923945126,0.5693026076054872
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,JUVENILE IDIOPATHIC ARTHRITIS,NCT03725007,Phase 1,0.5477202021016163,0.4522797978983837
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT04451772,Phase 2,0.4448254589523327,0.5551745410476673
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SPONDYLOARTHRITIS,NCT04169373,Phase 3,0.4359161357174306,0.5640838642825693
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ULCERATIVE COLITIS,NCT03006068,Phase 3,0.5268807991691166,0.4731192008308834
C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,_UBROGEPANT,MIGRAINE DISORDERS,NCT04492020,Phase 3,0.6140503898139298,0.3859496101860704
